See also this year's filing and all EDGAR filings for this company.
PDF Report 0001080709_2014_Arena_Pharmaceuticals_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': 23.696058784235138, 'aggregate_val': 36970000, 'exp_sum': 1497000, 'exp_to_value': {'remainder_Revenues': 1497000}} |
Graph
Absolute values for 0001080709, Arena Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 248,810,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 10,182,000 |
| 2 | PropertyPlantAndEquipmentNet | 77,388,000 |
| 3 | remainder_Assets | 3,427,000 |
| 4 | LiabilitiesCurrent | 70,744,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 31,681,000 |
| 9 | ResearchAndDevelopmentExpense | 66,468,000 |
| 10 | remainder_Expenses | 6,180,000 |
| 11 | remainder_Revenues | 81,394,000 |
| 12 | remainder_NetIncome | 3,500,000 |
| 13 | remainder_ComprehensiveNetIncome | 239,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 339,807,000 |
| 1 | Liabilities | 70,744,000 |
| 2 | Expenses | 104,329,000 |
| 3 | Revenues | 81,394,000 |
| 4 | StockholdersEquity | 269,063,000 |
| 5 | NetIncome | -19,435,000 |
| 6 | ComprehensiveNetIncome | -19,315,500 |
| 7 | BaseVar | 300,006,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 2.76 |
| 9 | EconomicCapitalRatio | 3.53 |
Edgar->Model Mapping
Feature Distribution
Change over Time
